Alvotech’s Ustekinumab Passes Safety And Efficacy Milestone

Company Reports Fresh Data For AVT04 Biosimilar Rival To Stelara

 
• By David Wallace
  
Clinical Trial Icon
Alvotech has reported further clinical trial results for its ustekinumab candidate • Source: Shutterstock

More from Biosimilars

More from Products